An early study reported that activation of the HCRTR2 pathway could combat diet-induced metabolic dysfunction by increasing energy expenditure and improving leptin sensitivity, positioning it as a potential therapeutic target for obesity and related disorders [60]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.